These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 27931266)
1. Letter to the Editor: Sodium nitroprusside for schizophrenia: could methodological variables account for the different results obtained? Maia-de-Oliveira JP; Baker GB; Dursun SM; Hallak JE Psychol Med; 2017 Apr; 47(5):981-982. PubMed ID: 27931266 [No Abstract] [Full Text] [Related]
2. Reply to: Letter to the Editor: Sodium nitroprusside for schizophrenia: could methodological variables account for the different results obtained? Stone J; Koychev I; Reilly T; McGuire P Psychol Med; 2017 Apr; 47(5):983. PubMed ID: 28112079 [No Abstract] [Full Text] [Related]
5. Sodium nitroprusside, a nitric oxide donor for novel treatment of schizophrenia, may also modulate dopaminergic systems. Maia-de-Oliveira JP; Lobão-Soares B; Baker GB; Dursun SM; Hallak JE Schizophr Res; 2014 Nov; 159(2-3):558-9. PubMed ID: 25223842 [No Abstract] [Full Text] [Related]
6. The effect of sodium nitroprusside on psychotic symptoms and spatial working memory in patients with schizophrenia: a randomized, double-blind, placebo-controlled trial. Stone JM; Morrison PD; Koychev I; Gao F; Reilly TJ; Kolanko M; Mohammadinasab A; Kapur S; McGuire PK Psychol Med; 2016 Dec; 46(16):3443-3450. PubMed ID: 27655012 [TBL] [Abstract][Full Text] [Related]
7. Effects of nitric oxide-related compounds in the acute ketamine animal model of schizophrenia. Kandratavicius L; Balista PA; Wolf DC; Abrao J; Evora PR; Rodrigues AJ; Chaves C; Maia-de-Oliveira JP; Leite JP; Dursun SM; Baker GB; Guimaraes FS; Hallak JE BMC Neurosci; 2015 Mar; 16():9. PubMed ID: 25887360 [TBL] [Abstract][Full Text] [Related]
8. Nitroprusside single-dose prevents the psychosis-like behavior induced by ketamine in rats for up to one week. Maia-de-Oliveira JP; Lobão-Soares B; Ramalho T; Gavioli EC; Soares VP; Teixeira L; Baker GB; Dursun SM; Hallak JE Schizophr Res; 2015 Mar; 162(1-3):211-5. PubMed ID: 25586741 [TBL] [Abstract][Full Text] [Related]
9. Response to Kujawa et al. letter-to-the-editor. Sethuraman G; Taylor CC; Enerson M; Dunayevich E Schizophr Res; 2006 May; 84(1):172-3. PubMed ID: 16563702 [No Abstract] [Full Text] [Related]
10. Letter to the editor: a comment on 'a systematic review of the effects of antipsychotic drugs on brain volume' by Moncrieff & Leo (2010). VAN Haren N; Kahn R Psychol Med; 2010 Dec; 40(12):2105-6; author reply 2106-7. PubMed ID: 20860864 [No Abstract] [Full Text] [Related]
11. Letter to the Editor: are antipsychotics good or bad for the brain? A comment on Moncrieff & Leo (2010). Dazzan P Psychol Med; 2010 Dec; 40(12):2107-8; author reply 2108. PubMed ID: 20810000 [No Abstract] [Full Text] [Related]
12. [Letter to the editor]. Román González N; Quintana Holgado A; Himénez Hernández MP Farm Hosp; 2013; 37(1):75-6. PubMed ID: 23461505 [No Abstract] [Full Text] [Related]
13. [Clinical pharmacology of sodium nitroprusside]. Campan L Neurochirurgie; 1978; 24(3):144-9. PubMed ID: 39269 [No Abstract] [Full Text] [Related]
14. The nitric oxide donor sodium nitroprusside attenuates recognition memory deficits and social withdrawal produced by the NMDA receptor antagonist ketamine and induces anxiolytic-like behaviour in rats. Trevlopoulou A; Touzlatzi N; Pitsikas N Psychopharmacology (Berl); 2016 Mar; 233(6):1045-54. PubMed ID: 26685991 [TBL] [Abstract][Full Text] [Related]
15. The effects of sodium nitroprusside treatment on cognitive deficits in schizophrenia: a pilot study. Maia-de-Oliveira JP; Abrao J; Evora PR; Zuardi AW; Crippa JA; Belmonte-de-Abreu P; Baker GB; Dursun SM; Hallak JE J Clin Psychopharmacol; 2015 Feb; 35(1):83-5. PubMed ID: 25502490 [No Abstract] [Full Text] [Related]
16. Efficacy and safety of oral propranolol premedication to reduce reflex tachycardia during hypotensive anesthesia with sodium nitroprusside in orthognathic surgery: a double-blind randomized clinical trial. Apipan B; Rummasak D J Oral Maxillofac Surg; 2010 Jan; 68(1):120-4. PubMed ID: 20006165 [TBL] [Abstract][Full Text] [Related]
17. Impact of atypical antipsychotics on quality of life in patients with schizophrenia. Awad AG; Voruganti LN CNS Drugs; 2004; 18(13):877-93. PubMed ID: 15521791 [TBL] [Abstract][Full Text] [Related]
18. [Letter to the editor: on the articles by Klimitz H. "Psychoeducation in schizophrenic disorders--psychotherapy or 'infiltration'?" and Bäuml J. "Psychoeducation from a psychiatric-psychotherapeutic point of view". Psychiat Prax 2006; 33: 372-382 ]. Böhme F Psychiatr Prax; 2007 Mar; 34(2):101-2. PubMed ID: 17390267 [No Abstract] [Full Text] [Related]
19. Celecoxib Adjunctive Treatment to Antipsychotics in Schizophrenia: A Review of Randomized Clinical Add-On Trials. Marini S; De Berardis D; Vellante F; Santacroce R; Orsolini L; Valchera A; Girinelli G; Carano A; Fornaro M; Gambi F; Martinotti G; Di Giannantonio M Mediators Inflamm; 2016; 2016():3476240. PubMed ID: 27524864 [TBL] [Abstract][Full Text] [Related]
20. Effect of sodium nitroprusside on cerebral haemodynamics during cross-clamping of the descending thoracic aorta in pigs. Strømholm T; Aadahl P; Saether OD; Aakhus S; Myhre HO Eur J Surg; 1996 Apr; 162(4):329-34. PubMed ID: 8739421 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]